UBS Group AG Registered Ordinary Shares (UBS)
37.35
+0.68 (1.85%)
NYSE · Last Trade: Aug 5th, 1:56 AM EDT
Detailed Quote
| Previous Close | 36.67 |
|---|---|
| Open | 37.56 |
| Bid | 37.16 |
| Ask | 38.50 |
| Day's Range | 37.26 - 37.56 |
| 52 Week Range | 25.75 - 38.42 |
| Volume | 1,483,581 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | 0.7000 (1.87%) |
| 1 Month Average Volume | 2,157,593 |
Chart
About UBS Group AG Registered Ordinary Shares (UBS)
UBS Group AG is a global financial services company providing a wide range of financial services to clients, including wealth management, investment banking, and asset management. The firm caters to private, corporate, and institutional clients, delivering tailored financial solutions and expertise across various sectors and regions. UBS is known for its strong focus on sustainable finance and innovation, striving to create long-term value for its stakeholders while maintaining a commitment to corporate responsibility and ethical practices in the financial industry. Read More
News & Press Releases
The AI chip maker received high marks from pundits tracking its fortunes.
Via The Motley Fool · August 4, 2025
Shares of tech giant Microsoft (NASDAQ:MSFT) jumped 2.6% in the afternoon session after investor optimism continued as the company received a series of analyst price target upgrades.
Via StockStory · August 4, 2025
Shares of luxury fashion conglomerate Tapestry (NYSE:TPR)
jumped 3.6% in the afternoon session after the company completed the sale of its Stuart Weitzman brand, a strategic move that coincided with a broader market rally in consumer stocks. The divestment allowed Tapestry to concentrate its resources on its core Coach and Kate Spade brands. This corporate news was bolstered by a favorable economic backdrop, as weak U.S. jobs data fueled investor hopes for a potential interest rate cut by the Federal Reserve. The prospect of lower borrowing costs typically encouraged consumer spending, which benefited companies like Tapestry. Adding to the positive momentum, a UBS analyst maintained a neutral stance but significantly raised the price target on the stock.
Via StockStory · August 4, 2025
In the 2017 agreement, Credit Suisse agreed to pay $5.7 billion as settlement fees for hiding the actual value of mortgage-backed securities ahead of the 2008 financial crisis.
Via Stocktwits · August 4, 2025
The main culprit: disappointing guidance.
Via The Motley Fool · August 1, 2025
Shares of outerwear manufacturer Columbia Sportswear (NASDAQ:COLM)
fell 14.6% in the morning session after the company issued a disappointing financial forecast for its third quarter and the full year, which overshadowed a second-quarter earnings beat.
Via StockStory · August 1, 2025
The S&P 500 generated tremendous returns over the last decade, but Wall Street analysts generally see little upside in the remaining months of 2025.
Via The Motley Fool · August 1, 2025
There's no news to report this week, but that's not stopping investors from clicking the "buy" button.
Via The Motley Fool · July 31, 2025
A Wall Street analyst upgraded the stock and increased the price target.
Via The Motley Fool · July 31, 2025
Shares of real estate technology company Compass (NYSE:COMP) jumped 10.2% in the afternoon session after the company reported record-breaking financial results for its second quarter, outperforming a declining real estate market. The real estate technology company announced its GAAP Net Income grew by 90.3% year-over-year to a record $39.4 million. Compass also expanded its market share to a new high of 6.09%, attracting a record 832 principal agents during the quarter. The company's total transactions surged by 20.9%, a stark contrast to the wider market, which experienced a 0.9% contraction. This performance was underpinned by a 21.1% rise in revenue to $2.06 billion. Following the strong report, a UBS analyst raised the price target on the stock, reflecting renewed confidence.
Via StockStory · July 31, 2025
Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY)
fell 4.2% in the afternoon session after the company lowered its full-year earnings forecast, overshadowing second-quarter results that beat revenue expectations. The drugmaker trimmed its adjusted earnings per share guidance for 2025, attributing the cut to a $0.57 per share charge from a partnership with BioNTech. This charge also hit second-quarter net income, which fell compared to the prior year. Beyond the one-time charge, the company's results revealed underlying weakness, as sales from its older drugs declined 14% due to generic competition. Specifically, revenue from the cancer drug Revlimid plunged 38% year-over-year. Even though Bristol-Myers raised its annual sales forecast, the reduced profit outlook appeared to sour investor sentiment.
Via StockStory · July 31, 2025
Retail sentiment has been bearish, and the Chinese company's Hong Kong shares declined on Thursday.
Via Stocktwits · July 31, 2025
Shares of the workout bike company are trading at a favorable risk/reward and "undemanding" valuation, according to the analyst.
Via Stocktwits · July 31, 2025
Shares of freight delivery company Landstar (NASDAQ:LSTR)
fell 3.3% in the morning session after the company reported second-quarter financial results that revealed a significant drop in year-over-year profitability, leading to several analyst price target cuts.
Via StockStory · July 30, 2025
Shares of online marketplace Etsy (NASDAQ:ETSY)
jumped 5.5% in the morning session after the company reported second-quarter financial results that showed revenue growth despite a drop in gross merchandise sales.
Via StockStory · July 30, 2025
Priced at a low-teens valuation, Peloton looks like a good value stock.
Via The Motley Fool · July 30, 2025
Amazon stock is underperforming the S&P 500, with a chance to boost its standing through Q2 results due Thursday.
Via Investor's Business Daily · July 30, 2025
Shares of health coverage company Centene (NYSE:CNC)
fell 3.3% in the morning session after JPMorgan cut its price target on the managed care company to $30 from $48. This move by JPMorgan followed Centene's recent second-quarter earnings report, where the company posted a loss of $0.16 per share, missing analyst estimates. The poor results were largely attributed to a significant reduction in the company's net 2025 Marketplace risk adjustment revenue transfer estimate, an issue that first came to light when Centene withdrew its full-year guidance on July 1st. The company's performance prompted a series of downgrades from Wall Street, with firms like UBS, Wells Fargo, and Morgan Stanley also cutting their price targets, signaling widespread concern over the company's ability to restore its earnings trajectory.
Via StockStory · July 29, 2025
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP)
fell 3.3% in the morning session after UBS downgraded the stock to 'Sell' from 'Neutral', sending shares lower. The investment bank expressed concerns that Medpace's near and mid-term financial targets appeared "overly ambitious" given a weak industry environment. UBS noted that meeting its objectives would require record bookings in the second half of the year, which seemed challenging due to several negative factors. These factors included weak biotech capital markets, fewer clinical trial starts, and muted hiring. The downgrade came despite a slight increase in the firm's price target on the stock to $305 from $300. Recent news of significant stock sales by the company's President and CFO also may have contributed to investor concerns.
Via StockStory · July 29, 2025
Shares of semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) jumped 19.3% in the morning session after the company reported strong second-quarter financial results that significantly beat analyst expectations and provided a robust outlook. The semiconductor packaging and test services provider posted earnings per share of $0.22, surpassing the forecasted $0.16. Revenue reached $1.51 billion, which was also ahead of the $1.42 billion consensus estimate. The company noted a 14% sequential increase in sales, with double-digit growth across all its end markets, highlighting strong demand in Artificial Intelligence (AI) and high-performance computing (HPC). In response to the strong quarter and positive guidance, analysts at Needham raised their price target on the stock to $28, while UBS increased its target to $25, with both firms maintaining their Buy ratings.
Via StockStory · July 29, 2025
Circle has minted native USDC on Sei and activated CCTP V2, enabling sub-second, slippage-free stablecoin flows across 13 chains.
Via Stocktwits · July 29, 2025
According to Fiscal.ai data, Wall Street expects the parcel delivery firm to post earnings of $1.57 per share on revenue $20.85 billion for the second quarter.
Via Stocktwits · July 29, 2025
Shares of clothing and footwear retailer Boot Barn (NYSE:BOOT)
jumped 3.1% in the morning session after analysts at JPMorgan Chase & Co. and Piper Sandler raised their price targets on the stock, signaling confidence in the company's outlook.
Via StockStory · July 28, 2025